Hereditary and acquired diseases of acyl-coenzyme A metabolism

Molecular Genetics and Metabolism

Volumn 94, Issue 1, 2008, Pages 4-15

  Mitchell, Grant A ^a   Gauthier, Nicolas ^a   Lesimple, Alain ^b   Wang, Shu Pei ^a   Mamer, Orval ^b   Qureshi, Ijaz ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Amino acid metabolism; Coenzyme A; Expanded newborn screening; Fatty acid metabolism; Inborn errors; Organic acids; Pathophysiology

Indexed keywords

ACETYL COENZYME A; CARBOXYLIC ACID; CARNITINE; ESTER DERIVATIVE; FUNCTIONAL GROUP; GLUTAMIC ACID; GLYCINE; PANTOTHENIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; CASTOR DISEASE; CELL FUNCTION; CELL TRANSPORT; CHRONIC DISEASE; CIRCULATION; CYTOTOXICITY; DIET RESTRICTION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SYNTHESIS; ENZYMURIA; GENE THERAPY; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HYDROLYSIS; INTRACELLULAR SPACE; MEMBRANE TRANSPORT; METABOLITE; MITOCHONDRION; NEWBORN SCREENING; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; PRIORITY JOURNAL; RELIABILITY; REVIEW; TRANSESTERIFICATION;

ACYL COENZYME A; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; MITOCHONDRIA; NEONATAL SCREENING;

EID: 41949122731     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.12.005     Document Type: Review

References (104)

1. Knights K.M. Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids. Clin. Exp. Pharmacol. Physiol. 25 10 (1998) 776-782
2. Tanaka K., Kean E.A., and Johnson B. Jamaican vomiting sickness. Biochemical investigation of two cases. N. Engl. J. Med. 295 9 (1976) 461-467
3. Melde K., Jackson S., Bartlett K., Sherratt H., and Shisla S. Metabolic consequence of methylenecyclopropylglycine poisoning in rats. Biochem. J. 274 (1991) 395-400
4. Leonardi R., Zhang Y.M., Rock C.O., and Jackowski S. Coenzyme A: back in action. Prog. Lipid Res. 44 2-3 (2005) 125-153
5. Tahiliani A.G., and Beinlich C.J. Pantothenic acid in health and disease. Vitam. Horm. 46 (1991) 165-228
6. Thurston J.H., and Hauhart R.E. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance. Pediatr. Res. 31 (1992) 419-423
7. Palekar A. Effect of pantothenic acid on hippurate formation in sodium benzoate-treated HepG2 cells. Pediatr. Res. 48 3 (2000) 357-359
8. Zhang Y.M., Rock C.O., and Jackowski S. Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters. J. Biol. Chem. 280 38 (2005) 32594-32601
9. Johnson M.A., Kuo Y.M., Westaway S.K., et al. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. Ann. NY Acad. Sci. 1012 (2004) 282-298
10. Hayflick S.J., Westaway S.K., Levinson B., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J. Med. 348 1 (2003) 33-40
11. Kotzbauer P.T., Truax A.C., Trojanowski J.Q., and Lee V.M. Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J. Neurosci. 25 3 (2005) 689-698
12. Kuo Y.M., Hayflick S.J., and Gitschier J. Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration. J. Inherit. Metab. Dis. 30 3 (2007) 310-317
13. Tahiliani A.G. Dependence of mitochondrial coenzyme A uptake on the membrane electrical gradient. J. Biol. Chem. 264 31 (1989) 18426-18432
14. Prohl C., Pelzer W., Diekert K., et al. The yeast mitochondrial carrier Leu5p and its human homologue Graves' disease protein are required for accumulation of coenzyme A in the matrix. Mol. Cell. Biol. 21 4 (2001) 1089-1097
15. Tholen H., and Mordhorst R. Hepatic and cerebral coenzyme A contents after intravenous injection of coenzyme A in rats. Experientia 32 7 (1976) 830-832
16. Newsholme E.A., and Leech A.R. Biochemistry for the Medical Sciences (1983), John Wiley & Sons, New York, NY
17. http://nobelprize.org/nobel_prizes/medicine/laureates/1953/lipmann-lecture.pdf.
18. Mashek D.G., Bornfeldt K.E., Coleman R.A., et al. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J. Lipid Res. 45 10 (2004) 1958-1961
19. Li L.O., Mashek D.G., An J., Doughman S.D., Newgard C.B., and Coleman R.A. Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J. Biol. Chem. 281 48 (2006) 37246-37255
20. Steinberg S.J., Morgenthaler J., Heinzer A.K., Smith K.D., and Watkins P.A. Very long-chain acyl-CoA synthetases. Human "bubblegum" represents a new family of proteins capable of activating very long-chain fatty acids. J. Biol. Chem. 275 45 (2000) 35162-35169
21. Pei Z., Fraisl P., Berger J., Jia Z., Forss-Petter S., and Watkins P.A. Mouse very long-chain acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J. Biol. Chem. 279 52 (2004) 54454-54462
22. Vessey D.A., and Kelley M. Purification and partial sequencing of the XL-I form of xenobiotic-metabolizing medium chain fatty acid:CoA ligase from bovine liver mitochondria, and its homology with the essential hypertension protein. Biochim. Biophys. Acta 1346 3 (1997) 231-236
23. Vessey D.A., Kelley M., and Warren R.S. Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids. Biochim. Biophys. Acta 1428 2-3 (1999) 455-462
24. Vessey D.A., Lau E., Kelley M., and Warren R.S. Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondria. J. Biochem. Mol. Toxicol. 17 1 (2003) 1-6
25. Fujino T., Takei Y.A., Sone H., et al. Molecular identification and characterization of two medium-chain acyl-CoA synthetases, MACS1 and the Sa gene product. J. Biol. Chem. 276 38 (2001) 35961-35966
26. Zhang Y.M., Chohnan S., Virga K.G., et al. Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. Chem. Biol. 14 3 (2007) 291-302
27. Sasaki T., Minagawa M., Yamamoto T., and Ichihashi H. A case of the Rett syndrome with acute encephalopathy induced during calcium hopantenate treatment. Brain Dev. 13 1 (1991) 52-55
28. Nakanishi T., Funahashi S., Shimizu A., and Hayashi A. Urinary organic acids in elderly Japanese patients with ketosis and encephalopathy who have taken panto-yl-gamma-aminobutyrate, calcium salt (calcium hopantenate, HOPA). Clin. Chim. Acta 188 1 (1990) 85-90
29. Kimura A., Yoshida I., Ono E., et al. Acute encephalopathy with hyperammonemia and dicarboxylic aciduria during calcium hopantenate therapy: a patient report. Brain Dev. 8 6 (1986) 601-605
30. Matsumoto M., Kuhara T., Inoue Y., Shinka T., and Matsumoto I. Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes. J. Chromatogr. 562 1-2 (1991) 139-145
31. Noda S., Umezaki H., Yamamoto K., Araki T., Murakami T., and Ishii N. Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate. J. Neurol. Neurosurg. Psychiatry 51 4 (1988) 582-585
32. Faergeman N.J., and Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323 Pt. 1 (1997) 1-12
33. Knudsen J., Neergaard T.B., Gaigg B., Jensen M.V., and Hansen J.K. Role of acyl-CoA binding protein in acyl-CoA metabolism and acyl-CoA-mediated cell signaling. J. Nutr. 130 2S Suppl (2000) 294S-298S
34. Rolf B., Oudenampsen-Kruger E., Borchers T., et al. Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein. Biochim. Biophys. Acta 1259 3 (1995) 245-253
35. Ogiwara H., Tanabe T., Nikawa J., and Numa S. Inhibition of rat-liver acetyl-coenzyme-A carboxylase by palmitoyl-coenzyme A. Formation of equimolar enzyme-inhibitor complex. Eur. J. Biochem. 89 1 (1978) 33-41
36. Nikawa J., Tanabe T., Ogiwara H., Shiba T., and Numa S. Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase. FEBS Lett. 102 2 (1979) 223-226
37. Huang H., Atshaves B.P., Frolov A., Kier A.B., and Schroeder F. Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism. Biochemistry 44 30 (2005) 10282-10297
38. Idell-Wenger J.A., Grotyohann L.W., and Neely J.R. An improved method for isolation of mitochondria in high yields from normal, ischemic, and autolyzed rat hearts. Anal. Biochem. 125 2 (1982) 269-276
39. Idell-Wenger J.A., Grotyohann L.W., and Neely J.R. Coenzyme A and carnitine distribution in normal and ischemic hearts. J. Biol. Chem. 253 12 (1978) 4310-4318
40. Brass E.P., and Ruff L.J. Rat hepatic coenzyme A is redistributed in response to mitochondrial acyl-coenzyme A accumulation. J. Nutr. 122 (1992) 2094-2100
41. Tubbs P.K., and Garland P.B. Variations in tissue contents of coenzyme A thio esters and possible metabolic implications. Biochem. J. 93 3 (1964) 550-557
42. Brass E.P., and Hoppel C.L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem. J. 190 3 (1980) 495-504
43. Friolet R., Hoppeler H., and Krahenbuhl S. Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J. Clin. Invest. 94 4 (1994) 1490-1495
44. Corkey B.E., Martin-Requero A., Walajtys-Rode E., Williams R.J., and Williamson J.R. Regulation of the branched chain alpha-ketoacid pathway in liver. J. Biol. Chem. 257 16 (1982) 9668-9676
45. Williamson J.R., Martin-Requero A., Corkey B.E., Brandt M., and Rothman R. Interactions between α-ketoisovalerate propionate and fatty acids on gluconeogenesis and ureogenesis in isolated hepatocytes. In: Walser M., and Williamson J.R. (Eds). Metabolism and Clinical implications of Branched Chain Amino and Ketoacids (1981), Elsevier North Holland, Inc. 105-117
46. Hertz R., Magenheim J., Berman I., and Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392 6675 (1998) 512-516
47. Hertz R., Kalderon B., Byk T., et al. Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor-4{alpha}. J. Biol. Chem. 280 26 (2005) 24451-24461
48. Folmes C.D., and Lopaschuk G.D. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity. Cardiovasc. Res. 73 2 (2007) 278-287
49. Roepstorff C., Halberg N., Hillig T., et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 288 1 (2005) E133-E142
50. Coude F.X., Sweetman L., and Nyhan W.L. Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J. Clin. Invest. 64 6 (1979) 1544-1551
51. Gregersen N. The specific inhibition of the pyruvate dehydrogenase complex from pig kidney by propionyl-CoA and isovaleryl-Co-A. Biochem. Med. 26 1 (1981) 20-27
52. Hayasaka K., Narisawa K., Satoh T., et al. Glycine cleavage system in ketotic hyperglycinemia: a reduction of H-protein activity. Pediatr. Res. 16 1 (1982) 5-7
53. Stumpf D.A., McAfee J., Parks J.K., and Eguren L. Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria. Pediatr. Res. 14 (1980) 1127-1131
54. Coude F.X., Grimber G., Parvy P., Rabier D., and Petit F. Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. Biochem. J. 216 1 (1983) 233-236
55. Coude F.X., Grimber G., Parvy P., and Rabier D. Role of N-acetylglutamate and acetyl-CoA in the inhibition of ureagenesis by isovaleric acid in isolated rat hepatocytes. Biochim. Biophys. Acta 761 1 (1983) 13-16
56. Martin-Requero A., Corkey B.E., Cerdan S., Walajtys-Rode E., Parrilla R.L., and Williamson J.R. Interactions between alpha-ketoisovalerate metabolism and the pathways of gluconeogenesis and urea synthesis in isolated hepatocytes. J. Biol. Chem. 258 6 (1983) 3673-3681
57. Foster D.W. The role of the carnitine system in human metabolism. Ann. NY Acad. Sci. 1033 (2004) 1-16
58. Lahjouji K., Mitchell G.A., and Qureshi I.A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol. Genet. Metab. 73 4 (2001) 287-297
59. Harper P., Wadstrom C., and Cederblad G. Carnitine measurements in liver, muscle tissue, and blood in normal subjects. Clin. Chem. 39 4 (1993) 592-599
60. Brass E.P. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol. Rev. 54 4 (2002) 589-598
61. Cordente A.G., Lopez-Vinas E., Vazquez M.I., et al. Redesign of carnitine acetyltransferase specificity by protein engineering. J. Biol. Chem. 279 32 (2004) 33899-33908
62. Roe C.R., Millington D.S., Maltby D.A., Kahler S.G., and Bohan T.P. L-Carnitine therapy in isovaleric acidemia. J. Clin. Invest. 74 6 (1984) 2290-2295
63. Van Hove J.L., Kahler S.G., Millington D.S., et al. Intravenous l-carnitine and acetyl-l-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia. Pediatr. Res. 35 1 (1994) 96-101
64. Roe C.R., Millington D.S., Maltby D.A., Bohan T.P., and Hoppel C.L. L-Carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J. Clin. Invest. 73 6 (1984) 1785-1788
65. Lysiak W., Lilly K., DiLisa F., Toth P.P., and Bieber L.L. Quantitation of the effect of l-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J. Biol. Chem. 263 3 (1988) 1151-1156
66. Mawal Y.R., and Qureshi I.A. Purification to homogeneity of mitochondrial acyl CoA:glycine N-acyltransferase from human liver. Biochem. Biophys. Res. Commun. 205 2 (1994) 1373-1379
67. Kolvraa S., and Gregersen N. Acyl-CoA:glycine N-acyltransferase: organelle localization and affinity toward straight- and branched-chained acyl-CoA esters in rat liver. Biochem. Med. Metab. Biol. 36 1 (1986) 98-105
68. Nandi D.L., Lucas S.V., and Webster Jr. L.T. Benzoyl-coenzyme A:glycine N-acyltransferase and phenylacetyl-coenzyme A:glycine N-acyltransferase from bovine liver mitochondria. Purification and characterization. J. Biol. Chem. 254 15 (1979) 7230-7237
69. Mawal Y., Paradis K., and Qureshi I.A. Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J. Pediatr. 130 6 (1997) 1003-1007
70. Batshaw M.L., Brusilow S., Waber L., et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N. Engl. J. Med. 306 23 (1982) 1387-1392
71. Brusilow S.W. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res. 29 2 (1991) 147-150
72. Feoli-Fonseca J.C., Lambert M., Mitchell G.A., et al. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal. Biochem. Mol. Med. 57 1 (1996) 31-36
73. Schlenzig J.S., Poggi-Travert F., Laurent J., et al. Liver transplantation in two cases of propionic acidaemia. J. Inherit. Metab. Dis. 18 4 (1995) 448-461
74. Hunt M.C., Yamada J., Maltais L.J., Wright M.W., Podesta E.J., and Alexson S.E. A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. J. Lipid Res. 46 9 (2005) 2029-2032
75. Hunt M.C., and Alexson S.E. The role acyl-CoA thioesterases play in mediating intracellular lipid metabolism. Prog. Lipid Res. 41 2 (2002) 99-130
76. Hunt M.C., Rautanen A., Westin M.A., Svensson L.T., and Alexson S.E. Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. 20 11 (2006) 1855-1864
77. Alexson S.E.H., and Nedergaard J. A novel type of short- and medium-chain acyl-CoA hydrolases in brown adipose tissue mitochondria. J. Biol. Chem. 263 (1988) 13564-13571
78. Svensson L.T., Kilpelainen S.H., Hiltunen J.K., and Alexson S.E. Characterization and isolation of enzymes that hydrolyze short-chain acyl-CoA in rat-liver mitochondria. Eur. J. Biochem. 239 2 (1996) 526-531
79. Yamashita H., Itsuki A., Kimoto M., Hiemori M., and Tsuji H. Acetate generation in rat liver mitochondria; acetyl-CoA hydrolase activity is demonstrated by 3-ketoacyl-CoA thiolase. Biochim. Biophys. Acta 1761 1 (2006) 17-23
80. Ramsay R.R., and Zammit V.A. Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol. Aspects Med. 25 5-6 (2004) 475-493
81. Treacy E., Clow C., Mamer O.A., and Scriver C.R. Methylmalonic acidemia with a severe chemical but benign clinical phenotype. J. Pediatr. 122 3 (1993) 428-429
82. Brown G.K., Hunt S.M., Scholem R., et al. Beta-hydroxyisobutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. Pediatrics 70 4 (1982) 532-538
83. Loupatty F.J., Clayton P.T., Ruiter J.P., et al. Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. Am. J. Hum. Genet. 80 1 (2007) 195-199
84. Shimomura Y., Murakami T., Fujitsuka N., et al. Purification and partial characterization of 3-hydroxyisobutyryl-coenzyme A hydrolase of rat liver. J. Biol. Chem. 269 19 (1994) 14248-14253
85. Kovachy R.J., Copley S.D., and Allen R.H. Recognition, isolation, and characterization of rat liver D-methylmalonyl coenzyme A hydrolase. J. Biol. Chem. 258 18 (1983) 11415-11421
86. Saudubray J.-M., and Charpentier C. Clinical phenotypes: diagnosis/algorithms. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill Inc., New York 1327-1406
87. Sniderman L.C., Lambert M., Giguere R., et al. Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J. Pediatr. 134 6 (1999) 675-680
88. Koeberl D.D., Young S.P., Gregersen N.S., et al. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr. Res. 54 2 (2003) 219-223
89. Dantas M.F., Suormala T., Randolph A., et al. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. Hum. Mutat. 26 2 (2005) 164
90. Tortorelli S., Hahn S.H., Cowan T.M., Brewster T.G., Rinaldo P., and Matern D. The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol. Genet. Metab. 84 2 (2005) 137-143
91. Mitchell G.A., Grompe M., Lambert M., and Tanguay R.M. Hypertyrosinemia. In: Scriver C.S., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 1777-1806
92. Fernandes J., Saudubray J.-M., Van Der Berghe G., and Walter J.H. Inborn Metabolic Diseases. 4 ed. (2006), Springer, Heidelberg
93. Kolker S., Sauer S.W., Surtees R.A., and Leonard J.V. The aetiology of neurological complications of organic acidaemias-a role for the blood-brain barrier. J. Inherit. Metab. Dis. 29 6 (2006) 701-704
94. Hutson S.M., Theodore C.C., and Harper A.E. Regulation of leucine and α-ketoisocaproate metabolism in skeletal muscle. J. Biol. Chem. 253 (1978) 8126-8133
95. Chakrapani A., Sivakumar P., McKiernan P.J., and Leonard J.V. Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J. Pediatr. 140 2 (2002) 261-263
96. Kasahara M., Horikawa R., Tagawa M., et al. Current role of liver transplantation for methylmalonic acidemia: a review of the literature. Pediatr. Transplant 10 8 (2006) 943-947
97. Nyhan W.L., Gargus J.J., Boyle K., Selby R., and Koch R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur. J. Pediatr. 161 7 (2002) 377-379
98. Saudubray J.M., Touati G., Delonlay P., et al. Liver transplantation in propionic acidaemia. Eur. J. Pediatr. 158 Suppl 2 (1999) S65-S69
99. Zafeiriou D.I., Vargiami E., Mayapetek E., Augoustidou-Savvopoulou P., and Mitchell G.A. 3-Hydroxy-3-methylglutaryl coenzyme a lyase deficiency with reversible white matter changes after treatment. Pediatr. Neurol. 37 1 (2007) 47-50
100. Hoffmann G.F. Cerebral organic acid disorders and other disorders of lysine catabolism. In: Fernandes J., Saudubray J.-M., Van Der Berghe G., and Walter J.H. (Eds). Inborn Metabolic Diseases (2006), Springer, Heidelberg 293-306
101. Seijo-Martinez M., Navarro C., Castro del R.M., et al. l-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch. Neurol. 62 4 (2005) 666-670
102. Lopez-Laso E., Garcia-Villoria J., Martin E., Duque P., Cano A., and Ribes A. Classic and late-onset neurological disease in two siblings with glutaryl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 30 6 (2007) 979
103. Thompson G.N., Chalmers R.A., Walter J.H., et al. The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur. J. Pediatr. 149 11 (1990) 792-796
104. Watson M.S., Mann M.Y., Lloyd-Puryear M.A., Rinaldo P., and Howell R.R. Newborn screening: Toward a uniform screening panel and system. Executive summary. Genet. Med. 8 (2006) 1S-11S